Skip to main content
Journal cover image

NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress

Publication ,  Conference
Khasraw, M; McDonald, KL; Yip, S; Verhaak, R; Heimberger, A; Hall, M; Fisher, L; Barnes, E; Rosenthal, M; Gedye, C; Hovey, E; Ellingson, BM ...
Published in: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
November 1, 2018

Duke Scholars

Published In

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

EISSN

1743-7563

ISSN

1743-7555

Publication Date

November 1, 2018

Volume

14

Start / End Page

196 / 197

Publisher

WILEY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khasraw, M., McDonald, K. L., Yip, S., Verhaak, R., Heimberger, A., Hall, M., … Lwin, Z. (2018). NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress. In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (Vol. 14, pp. 196–197). WILEY.
Khasraw, Mustafa, Kerrie L. McDonald, Sonia Yip, Roel Verhaak, Amy Heimberger, Merryn Hall, Lauren Fisher, et al. “NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress.” In ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 14:196–97. WILEY, 2018.
Khasraw M, McDonald KL, Yip S, Verhaak R, Heimberger A, Hall M, et al. NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress. In: ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2018. p. 196–7.
Khasraw M, McDonald KL, Yip S, Verhaak R, Heimberger A, Hall M, Fisher L, Barnes E, Rosenthal M, Gedye C, Hovey E, Ellingson BM, Simes J, Tongela A, Wheeler H, Koh E-S, Gan H, Back M, Lwin Z. NUTMEG: A randomised phase II study of nivolumab and temozolomide (TMZ) versus TMZ alone in elderly patients with newly diagnosed glioblastoma (GBM): Trial in progress. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY; 2018. p. 196–197.
Journal cover image

Published In

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

EISSN

1743-7563

ISSN

1743-7555

Publication Date

November 1, 2018

Volume

14

Start / End Page

196 / 197

Publisher

WILEY

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis